| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 01/22/2009 | CA2688669A1 New combinations for the treatment of respiratory diseases |
| 01/21/2009 | EP2016953A2 Vascular endothelial cell growth factor antagonists and uses thereof |
| 01/21/2009 | EP2016948A2 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
| 01/21/2009 | EP2016945A1 Pharmaceutical containing thiazole derivative as active ingredient |
| 01/21/2009 | EP2016074A1 Inhibitors of c-fms kinase |
| 01/21/2009 | EP2016070A1 Inhibitors of c-fms kinase |
| 01/21/2009 | EP2016065A2 1-(benzo[d][1,3]dioxol-5-yl)-n-(phenyl)cyclopropane-carboxamide derivatives and related compounds as modulators of atp-binding cassette transporters for the treatment of cystic fibrosis |
| 01/21/2009 | EP2016063A1 Thiazole derivatives as inhibitors of p13 kinase |
| 01/21/2009 | EP2016058A1 Inhibitors of c-fms kinase |
| 01/21/2009 | EP2015769A2 Pharmaceutical compositions of hglp-1, exendin-4 and analogs thereof |
| 01/21/2009 | EP1845994B1 Combination of methylxanthine compounds and steroids to treat chronic respiratory diseases |
| 01/21/2009 | EP1663983B1 N-substituted, 6,8-dialkoxy-1,2,3,4-tetrahydro-1h-isoquinoline as potassium channels modulators |
| 01/21/2009 | EP1613315B1 Quinoline-2-one-derivatives for the treatment of airways diseases |
| 01/21/2009 | EP1487273B1 Compositions and methods for treatment of microbial infections |
| 01/21/2009 | EP1399563B1 Moraxella (branhamella) catarrhalis antigens |
| 01/21/2009 | EP0850053B1 Erythrocytes loaded with s-nitrosothiol and uses therefor |
| 01/21/2009 | CN101351557A Gene transfer into airway epithelial stem cell by using lentiviral vector pseudotyped with RNA virus or DNA virus spike protein |
| 01/21/2009 | CN101351466A Heterocyclic Janus kinase 3 inhibitors |
| 01/21/2009 | CN101351465A 3 -monosubstituted tropane derivatives as nociceptin receptor ligands |
| 01/21/2009 | CN101351448A Novel 1 -benzyl-4-piperidinamines that are useful in the treatment of COPD and asthma |
| 01/21/2009 | CN101351216A Compositions comprising IGBPMA and uses thereof |
| 01/21/2009 | CN101348761A Health care wine |
| 01/21/2009 | CN101348455A Aspartic acid specificity cysteine proteinase inhibitors and uses thereof |
| 01/21/2009 | CN101347621A Medicament composition for treating respiratory disease |
| 01/21/2009 | CN101347618A Medicament composition for treating respiratory disease |
| 01/21/2009 | CN101347612A Compound medicament for treating common cold cough and acute/chronic bronchitis, and preparation method thereof |
| 01/21/2009 | CN101347569A Chinese medicine preparation for treating bronchial asthma |
| 01/21/2009 | CN101347550A Medicament for treating rhinitis |
| 01/21/2009 | CN101347532A Spray for quick healing of burn |
| 01/21/2009 | CN101347522A Nano 'Shuang Hualian' injection preparation for fowl and preparation thereof |
| 01/21/2009 | CN101347514A Health medical pillow |
| 01/21/2009 | CN101347505A Chai huang granule and uses thereof |
| 01/21/2009 | CN101347488A Uses of plants from genera Cynoglossum of family Boraginaceae and extract thereof in preparing medicament for treating respiratory illness |
| 01/21/2009 | CN101347470A Glossy privet fruit total triterpenes extract and total phenols extract as well as preparation method thereof |
| 01/21/2009 | CN101347465A Xylaria nigripes fermentation liquor powder and preparation and use |
| 01/21/2009 | CN101347437A Medicament composition for treating respiratory disease |
| 01/21/2009 | CN101347436A Uses of methylprednisolone and derivatives thereof in preparing medicament for treating allergic rhinitis |
| 01/21/2009 | CN101347433A Pharmacy use of 4-aniline quinazoline derivatives |
| 01/21/2009 | CN101347430A Pseudoephedrine hydrochloride oral administration solution and method of preparing the same |
| 01/21/2009 | CN101347416A Capsules type acetaminopher drop and method of preparing the same |
| 01/21/2009 | CN100453530C Compounds and methods for inhibition of expression of VCAM-1 |
| 01/21/2009 | CN100453529C Aryl sulfonamides and analogues thereof and their use in treatment of neurodegenerative diseases |
| 01/21/2009 | CN100453116C Process for preparing compound aminophylline tablet |
| 01/21/2009 | CN100453111C Medicine for treating infants cough and preparation method thereof |
| 01/21/2009 | CN100453107C Natural botanical extraction liquid for preventing and treating livestock and birds respiratory disease and preparation process thereof |
| 01/21/2009 | CN100453106C Chinese medicine compound preparation for treating laryngopharyngitis and tonsillitis and its preparing method |
| 01/21/2009 | CN100453101C Medicine for treating bronchitic asthma and chronic bronchitis and its prepn. method |
| 01/21/2009 | CN100453096C Chinese globeflower soft capsule and its preparation method |
| 01/21/2009 | CN100453073C Compound radical lobelia dripping pill and its preparing method |
| 01/21/2009 | CN100453072C Isatis root drops and preparation thereof |
| 01/21/2009 | CN100452997C Method for preparing loquat flower syrup |
| 01/20/2009 | US7479564 e.g. 6-ethyl-5-(4-{2-[({[(4-methylphenyl)sulfonyl]amino}carbonyl)amino]ethyl}phenyl)-5H-[1,3]dioxolo[4,5-f]benzimidazole; prostaglandin E2 receptor antagonists; arthritis, hyperalgesia, uterine contraction, digestive peristalsis, awakeness, blood pressure, platelet function, bone metabolism, angiogenesis |
| 01/20/2009 | US7479504 Edg receptor agonists |
| 01/20/2009 | US7479501 Heteroaryl-cyclic acetals |
| 01/20/2009 | CA2586146C Fluorocarbon aerosol medicaments |
| 01/20/2009 | CA2465871C Heteroaryl derivatives as superior ligands for nociceptin receptor orl-1 |
| 01/20/2009 | CA2401048C 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 01/20/2009 | CA2376676C Respiratory syncytial virus replication inhibitors |
| 01/20/2009 | CA2372836C Substituted pyrrolidines as cell adhesion inhibitors |
| 01/20/2009 | CA2352483C Pharmaceutical aerosol composition containing hfa 227 and hfa 134a |
| 01/20/2009 | CA2337770C Amide derivatives which are useful as cytokine inhibitors |
| 01/20/2009 | CA2213660C Aerosol containing beclamethasone nanoparticle dispersions |
| 01/15/2009 | WO2009009173A2 Klotho-beta for use in treating cancer, liver disorders, gallstones, wasting syndrome and obesity-related diseases |
| 01/15/2009 | WO2009007750A1 Morpholino pyrimidine derivatives used in diseases linked to mtor kinase and/or pi3k |
| 01/15/2009 | WO2009007747A2 Hydantoin derivatives used as mmp12 inhibitors |
| 01/15/2009 | WO2009007687A2 An inhalable medicament |
| 01/15/2009 | WO2009007420A1 Novel bronchodilating alpha, beta-unsaturated isoquinoline amides |
| 01/15/2009 | WO2009007419A1 Novel bronchodilating isoquinoline carbamates |
| 01/15/2009 | WO2009007418A1 Novel bronchodilating isoquinoline amides |
| 01/15/2009 | WO2009007110A2 Combination of benzyl-4,5-dihydro-1h-imidazole derivative and an opiod recptor ligand |
| 01/15/2009 | WO2009006688A1 Regulating il-4 and il- 13 levels by blocking high affinity binding by il-3, il-5 and gm-csf to their common receptor |
| 01/15/2009 | WO2008144473A3 Chimeric pufa polyketide synthase systems and uses thereof |
| 01/15/2009 | WO2008137027A3 Compounds as crth2 and/or pgd2 receptors modulators and their use for treating asthma and allergic inflammation |
| 01/15/2009 | WO2008063581A3 Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs |
| 01/15/2009 | WO2006003222A9 Use of formoterol in the prophylactic and/or therapeutic treatment of muscle wasting and/or cachectic syndrome which are associated with catabolic conditions of certain diseases, such as cancer, aids, infections, diabetes and others |
| 01/15/2009 | US20090018184 Polyether Brevetoxin Derivatives as a Treatment for Cystic Fibrosis, Mucociliary Dysfunction, and Pulmonary Diseases |
| 01/15/2009 | US20090018170 5-lipoxygenase-activating protein (flap) inhibitors |
| 01/15/2009 | US20090018165 Biphenyl compounds useful as muscarinic receptor antagonists |
| 01/15/2009 | US20090018144 Capped pyrazinoylguanidine sodium channel blockers |
| 01/15/2009 | US20090018139 Treatment of CRTH2-mediated diseases and conditions |
| 01/15/2009 | US20090018138 Treatment of CRTH2-mediated diseases and conditions |
| 01/15/2009 | US20090018133 Novel Adamantane Derivatives |
| 01/15/2009 | US20090018114 Novel compounds as cannabinoid receptor ligands |
| 01/15/2009 | US20090018109 Combinations of steroids and methylxanthine compounds |
| 01/15/2009 | US20090018077 Fibroblast Growth Factor-Like Polypeptides |
| 01/15/2009 | US20090018076 Fibroblast Growth Factor-Like Polypeptides |
| 01/15/2009 | US20090018068 G-protein coupled receptors |
| 01/15/2009 | US20090017119 Modifications of solid 3-sn-phosphoglycerides |
| 01/15/2009 | US20090017037 Human TIMP-1 Antibodies |
| 01/15/2009 | US20090017036 Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders |
| 01/15/2009 | US20090017018 Uses of mammalian cytokine: related reagents |
| 01/15/2009 | US20090017014 Compositions and methods for the treatment of immune related diseases |
| 01/15/2009 | US20090017003 Thiosulfonate anti-inflammatory agents |
| 01/15/2009 | US20090016967 Compositions and methods for the treatment of respiratory disorders |
| 01/15/2009 | US20090013998 Inhalable tiotropium and container therefor |
| 01/15/2009 | US20090013652 Method and Apparatus for Loading a Container with a Product |
| 01/15/2009 | CA2692720A1 Morpholino pyrimidine derivatives used in diseases linked to mtor kinase and/or pi3k |
| 01/15/2009 | CA2692606A1 Inhalable solid amorphous particles comprising tiotropiium bromide and a co-solid |
| 01/15/2009 | CA2682096A1 Klotho beta |
| 01/14/2009 | EP2014776A2 Diagnosis of diseases associated with DNA transcription |